Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philip Harvey Morton is active.

Publication


Featured researches published by Philip Harvey Morton.


Biotechnology Progress | 2004

A Software Tool to Assist Business‐Process Decision‐Making in the Biopharmaceutical Industry

Mustafa A. Mustafa; John Washbrook; Ai Chye Lim; Yuhong Zhou; Nigel J. Titchener-Hooker; Philip Harvey Morton; Steve Berezenko; Suzanne S. Farid

Conventionally, software tools for the design of bioprocesses have provided only limited business‐related information for decision‐making. There is an industrial need to investigate manufacturing options and to gauge the impact of various decisions from economic as well as process perspectives. This paper describes the development and use of a tool to provide an assessment of whole flowsheets by capturing both process and business aspects. The tool is demonstrated by considering the issues concerned when making decisions between two potential flowsheets for a common product. A case study approach is used to compare the process and business benefits of a conventional process route employing packed chromatography beds and an alternative that uses expanded bed adsorption (EBA). The tool allows direct evaluation of the benefits of capital cost reduction and increased yield offered by EBA against penalties of using potentially more expensive EBA matrix with lower lifetimes. Furthermore, the tool provides the ability to gauge the process robustness of each flowsheet option.


Archive | 2000

Chromatographic process for purification of albumin

Urk Hendrik Van; David John Mead; Philip Harvey Morton; Andrew John Cartwright; Jason Cameron; David James Ballance; Michel Gaston Joseph Grandgeorge; Stephen Berezenko; John Rodney Woodrow; Darrell Sleep; Jean-Luc Bernard Veron


Archive | 2004

Method of quantifying the surfactant of a protein preparation

Philip Harvey Morton; Jason Cameron


Archive | 2004

Method for removing a proteinaceous component from a liquid-phase surfactant preparation

Philip Harvey Morton; Jason Cameron


Biotechnology Progress | 2005

A software tool to assist business-process decision-making in the bio-pharmaceutical industry (vol 20, pg 1096, 2004)

Ma Mustafa; John Washbrook; Ai Chye Lim; Yuhong Zhou; Nigel J. Titchener-Hooker; Philip Harvey Morton; S Berezenko; Suzanne S. Farid


Journal of Translational Medicine | 2018

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products

Clémentine Mirabel; Eduard Puente-Massaguer; Anna del Mazo-Barbara; Blanca Reyes; Philip Harvey Morton; Francesc Gòdia; Joaquim Vives


Biotechnology Progress | 2005

Erratum: A software tool to assist business-process decision-making in the biopharmaceutical industry (Biotechnology Progress (2004) 20 (1096-1102))

Ma Mustafa; John Washbrook; Cl Ai; Yuhong Zhou; Nigel J. Titchener-Hooker; Philip Harvey Morton; S Berezenko; Suzanne S. Farid


Archive | 2004

Verfahren zur tensid-quantifizierung eines proteinpräparates A method for surfactant-quantification of a protein preparation

Philip Harvey Morton; Jason Cameron


Archive | 2004

Quantification method of surfactant protein preparation.

Jason Cameron; Philip Harvey Morton


Archive | 2000

Procédé chromatographique de purification de l'albumine

David James Ballance; Stephen Berezenko; Jason Cameron; Andrew John Cartwright; Michel Gaston Joseph Grandgeorge; David John Mead; Philip Harvey Morton; Darrell Sleep; Urk Hendrik Van; Jean-Luc Bernard Veron; John Rodney Woodrow

Collaboration


Dive into the Philip Harvey Morton's collaboration.

Top Co-Authors

Avatar

Jason Cameron

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

Darrell Sleep

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge